Skip to content
Abierto

Combined synopsis and solicitation, total small business set-aside

Animal Blood

CDRH2026134634

Food and Drug Administration, FDA Office of Acq Grant SVCS. Biological Product (except Diagnostic) Manufacturing.

Offers due

September 18, 2026 at 10:00 AM EDT

That is tomorrow. Posted September 16, 2026.

Description

As published on SAM.gov.

This is a synopsis of a procurement for commercial products prepared in accordance with the commercial acquisition procedures of RFO Part 12.

Solicitation No. 75F40126Q00362 was issued as a Request for Quotation (RFQ) for donor animal whole blood (bovine, ovine, and porcine) for the FDA Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Cardiovascular Program, Division of Applied Mechanics (DAM). The blood products support blood compatibility (hemocompatibility) testing and medical device research, including hemolysis- and thrombosis-related projects, as further described in Attachment 1 – Requirements Document.

All supplies shall meet the minimum requirements in Attachment 1 – Requirements Document, including species availability, minimum draw frequency, blood quality, minimum delivery volumes, anticoagulant type, labeling, quarantine protocol, veterinary oversight, AAALAC accreditation, and ISO 13485:2016 certification.

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 16, 2026

    Combined synopsis and solicitation

    Due September 18, 2026 at 10:00 AM EDT. SAM.gov, notice 25fcf047752f4c1e976f162e1c65a5a9

    1 revisions on SAM
    • September 16, 2026: publish, combined synopsis and solicitation

Points of contact